Chromatin News and Research

RSS
New imaging approach reveals dynamic and structural interactions of DNA in cell's nucleus

New imaging approach reveals dynamic and structural interactions of DNA in cell's nucleus

DNA-protein structure more diverse and flexible chain than previously thought, study reveals

DNA-protein structure more diverse and flexible chain than previously thought, study reveals

African-American patients have increased gene mutations in tobacco-related tumors, study finds

African-American patients have increased gene mutations in tobacco-related tumors, study finds

Wistar scientists discover new therapeutic strategy for difficult-to-treat form of ovarian cancer

Wistar scientists discover new therapeutic strategy for difficult-to-treat form of ovarian cancer

Study provides insights into intergenerational inheritance of epigenetic information

Study provides insights into intergenerational inheritance of epigenetic information

Researchers discover potential substitutes for BPA that lack adverse effects

Researchers discover potential substitutes for BPA that lack adverse effects

Biolegend chooses Chromatrap technology to power chromatin immunoprecipitation kits

Biolegend chooses Chromatrap technology to power chromatin immunoprecipitation kits

Study indicates new element involved in genome instability

Study indicates new element involved in genome instability

UNC researchers discover cascade of gene activity during journey to maturation in fruit flies

UNC researchers discover cascade of gene activity during journey to maturation in fruit flies

Chromatrap introduces new FFPE ChIP-seq assay kit for tissue samples, biopsies, and difficult to lyse samples

Chromatrap introduces new FFPE ChIP-seq assay kit for tissue samples, biopsies, and difficult to lyse samples

New and improved solid phase ChIP assay kit for FFPE tissues introduced by Chromatrap

New and improved solid phase ChIP assay kit for FFPE tissues introduced by Chromatrap

NETRF announces $4 million in collaborative grants to study neuroendocrine tumors

NETRF announces $4 million in collaborative grants to study neuroendocrine tumors

Researchers shed light on genome reorganization after fertilization in single-cell mammalian embryo

Researchers shed light on genome reorganization after fertilization in single-cell mammalian embryo

Combining anticancer drug with antirheumatic produces improved effects against tumors

Combining anticancer drug with antirheumatic produces improved effects against tumors

Study reveals intriguing crosstalk between metabolism and epigenetics in cancer development

Study reveals intriguing crosstalk between metabolism and epigenetics in cancer development

Chromatrap publishes new article comparing efficiency, sensitivity of native and cross-linked ChIP-seq kits

Chromatrap publishes new article comparing efficiency, sensitivity of native and cross-linked ChIP-seq kits

New study correlates 80 cancer-related gene mutations with 34 AML subgroups

New study correlates 80 cancer-related gene mutations with 34 AML subgroups

York researchers move closer to finding new treatments for chronic bladder diseases

York researchers move closer to finding new treatments for chronic bladder diseases

Heroin use linked to epigenetic alterations in the brain

Heroin use linked to epigenetic alterations in the brain

Research findings could guide development of potent combination therapies for leukemia

Research findings could guide development of potent combination therapies for leukemia

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.